-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pt94gDIsln4WHxD7i23xMUpDPp/RPhx6Dbu0GBNrGTF/k2XV7trQwk8TiHPbIa04 F9vk0Hb82lDeYUTlGinYdw== 0001158833-02-000026.txt : 20020415 0001158833-02-000026.hdr.sgml : 20020415 ACCESSION NUMBER: 0001158833-02-000026 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020408 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIFE SCIENCES RESEARCH INC CENTRAL INDEX KEY: 0001158833 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 522340150 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-62457 FILM NUMBER: 02603977 BUSINESS ADDRESS: STREET 1: PMB #251, 211 EAST LOMBARD STREET CITY: BALTIMORE STATE: MD ZIP: 21202-6102 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAKER ANDREW H CENTRAL INDEX KEY: 0001037414 STATE OF INCORPORATION: MD FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 BUSINESS PHONE: 732-873-2550 MAIL ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 SC 13D 1 sched13dahb.txt SCHEDULE 13D, ANDREW H. BAKER SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. __________ )(1) Life Sciences Research, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Voting Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 5321691090 - -------------------------------------------------------------------------------- (CUSIP Number) Andrew H. Baker Life Sciences Research, Inc. P. O. Box 2360 Mettler Road East Millstone, NJ 08875 (732) 873-2550 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 28, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on following pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13D-07/99) CUSIP No.5321691090 13D ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Andrew H. Baker ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* PF, SC ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 2,699,175 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 2,699,175 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,699,175 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 24.4% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Focused Healthcare Partners, Ltd. ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* PF, SC ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Bahamas ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 684,000 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 684,000 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,000 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.2% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Focused Healthcare Partners, LLC ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* PF, SC ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 80,000 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 80,000 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 80,000 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.01% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) First Investments LLC ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* PF ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Nevada ________________________________________________________________________________ 7 SOLE VOTING POWER 0 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 1,835,175 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 1,835,175 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,835,175 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.6% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 13D ________________________________________________________________________________ Item 1. Security and Issuer. Class of Securities: Voting Common Stock, $.01 par value per share (the "Common Stock") Issuer: Life Sciences Research, Inc. (the "Issuer"), P.O. Box 2360, Mettler Road, East Millstone, NJ 08875 ________________________________________________________________________________ Item 2. Identity and Background. (a) Names: Andrew H. Baker ("Baker") Focused Healthcare Partners, Ltd. ("FHP Ltd") Focused Healthcare Partners, LLC ("FHP LLC") First Investments LLC ("FI") (b) Business Address: Andrew H. Baker c/o Life Sciences Research, Inc. P.O. Box 2360, Mettler Road East Millstone, NJ 08875 Focused Healthcare Partners, Ltd. c/o Life Sciences Research, Inc. P. O. Box 2360, Mettler Road East Millstone, NJ 08875 Focused Healthcare Partners, LLC c/o Life Sciences Research, Inc. P. O. Box 2360, Mettler Road East Millstone, NJ 08875 First Investments LLC 237 Tramway Drive, Box 6957 Lake Tahoe, NV 89449 (c) Principal Occupation or Employment: Baker: Chairman and CEO of the Issuer FHP Ltd Investments FHP LLC Investments FI Investments (d) Criminal Convictions: None. (e) Civil Adjudication of Violation of Securities Laws: None. (f) Citizenship: Baker: United Kingdom citizen FHP Ltd Bahamas corporation FHP LLC New Jersey limited liability company FI Nevada limited liability company ________________________________________________________________________________ Item 3. Source and Amount of Funds or Other Consideration. The Reporting Persons acquired Issuer's Common Stock as follows: (a) 204,000 shares of Common Stock of the Issuer were acquired in January 2002 by exchanging ordinary shares of Huntingdon Life Sciences Group plc ("Huntingdon") owned by FHP Ltd. for shares of the Issuer's Common Stock in the Issuer's exchange offer to acquire all outstanding equity securities of Huntingdon; (b) 1,400,000 shares of Common Stock of the Issuer were acquired in March 2002, in the Issuer's private placement of approximately 5.1 million shares of Common Stock at a per share purchase price of $1.50 (the "Private Placement"), by conversion of $2,100,000 owed to Mr.Baker under the terms of a 2,000,000 pound (approximately $2.9 million) Loan Facility Letter between Mr. Baker and Huntingdon. (c) 80,000 shares of Common Stock of the Issuer were acquired in March 2002 in the Private Placement by conversion of a portion of $300,000 owed to FHP LLC by the Issuer. (d) Beneficial ownership of 100,000 shares of Issuer's Common Stock is reflected by presently exercisable options to purchase Common Stock granted to Mr. Baker by the Issuer in March 2002. (e) 915,175 shares of Common Stock were acquired by FI in privately negotiated purchases in March 2002 in exchange for a 49% interest in FI (valued at a per share purchase price of the Issuer of $1.50 per share). ________________________________________________________________________________ Item 4. Purpose of Transaction. (a)-(j) The Reporting Persons acquired the shares for investment purposes. ________________________________________________________________________________ Item 5. Interest in Securities of the Issuer. (a) Beneficial Ownership by the Reporting Persons: Number of Shares ---------------- Baker: Aggregate number of shares: 2,699,175 Percentage: 24.4% (based on 11,032,578 outstanding shares) FHP Ltd: Aggregate number of shares: 684,000 Percentage: 6.2% (based on 11,032,578 outstanding shares) FHP LLC: Aggregate number of shares: 80,000 Percentage 0.01% (based on 11,032,578 outstanding shares) FI: Aggregate number of shares: 1,835,175 Percentage: 16.6% (based on 11,032,578 outstanding shares) (b) Baker: Sole Voting Power: 0 Shared Voting Power: 2,699,175 Sole Dispositive Power: 0 Shares Dispositive Power: 2,699,175 FHP Ltd: Sole Voting Power: 0 Shared Voting Power: 684,000 Sole Dispositive Power: 0 Shares Dispositive Power: 684,000 FHP LLC: Sole Voting Power: 0 Shared Voting Power: 80,000 Sole Dispositive Power: 0 Shares Dispositive Power: 80,000 FI: Sole Voting Power: 0 Shared Voting Power: 1,835,175 Sole Dispositive Power: 0 Shares Dispositive Power: 1,835,175 (c) (i) 1,400,000 shares of Common Stock of the Issuer were acquired in March 2002, in the Issuer's private placement of approximately 5.1 million shares of Common Stock at a per share purchase price of $1.50 (the "Private Placement"), by conversion of $2,100,000 owed to Mr. Baker under the terms of a 2,000,000 pound (approximately $2.9 million) Loan Facility Letter between Mr. Baker and Huntingdon. (ii) 80,000 shares of Common Stock of the Issuer were acquired in March 2002 in the Private Placement by conversion of a portion of $300,000 owed to FHP LLC by the Issuer. (iii)Beneficial ownership of 100,000 shares of Issuer's Common Stock is reflected by presently exercisable options to purchase Common Stock granted to Mr. Baker by the Issuer in march 2002. (iv) 915,175 shares of Common Stock were acquired in privately negotiated purchases in March 2002 at a per share purchase price of $1.50 per share. (d) Not applicable. (e) Not applicable. ________________________________________________________________________________ Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. FHP Ltd. is party to an operating agreement governing the operations of FI (the "FI Operating Agreement"). FI is the beneficial owner of 1,835,175 shares of Common Stock. The other party to such Operating Agreement is Search for a Cure LLC ("SFC"). FHP Ltd. owns approximately 51% of the membership interests of FI and SFC owns approximately 49% of such membership interests. By virtue of its majority ownership of FI, FHP Ltd. has voting and dispositive power over the LSR shares owned by FI. Profit distribution under the FI Operating Agreement will be made in proportion to the relative ownership interests of FHP Ltd. and SFC. ________________________________________________________________________________ Item 7. Material to be Filed as Exhibits. None. ________________________________________________________________________________ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. April 5, 2002 ---------------------------------------- (Date) /s/ Andrew H. Baker ---------------------------------------- (Signature) Andrew H. Baker ---------------------------------------- (Name/Title) Focused Healthcare Partners, Ltd. /s/ Andrew H. Baker By: ------------------------------------ Name: Andrew H. Baker Title: President Focused Healthcare Partners LLC /s/ Andrew H. Baker By: ----------------------------------- Name: Andrew H. Baker Title: Member First Investments LLC /s/ Andrew H. Baker By: ----------------------------------- Name: Andrew H. Baker Title: Treasurer Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EDGARLink 7.0 (8/00) Ver. 3.1 -----END PRIVACY-ENHANCED MESSAGE-----